Oct 12
|
AstraZeneca PLC (AZN): A Top Holding in George Soros’s Portfolio
|
Oct 9
|
Astrazeneca (AZN) Loses -5.29% in 4 Weeks, Here's Why a Trend Reversal May be Around the Corner
|
Oct 8
|
AstraZeneca Inks Agreement to Boost Cardiovascular Pipeline
|
Oct 8
|
Health Care Roundup: Market Talk
|
Oct 8
|
Want to Invest in the Weight Loss Boom? Consider Buying These 2 Stocks
|
Oct 8
|
AstraZeneca’s Phase III trial of treatment for asthma meets its primary endpoint
|
Oct 8
|
Zacks Industry Outlook Eli Lilly, AstraZeneca, Pfizer, Sanofi and Bayer
|
Oct 7
|
5 Large Drug Stocks to Watch From a Thriving Industry
|
Oct 7
|
AstraZeneca Inks $1.92B License Pact With Hong Kong-Based Firm To Boost Cardiovascular Pipeline
|
Oct 7
|
AIRSUPRA® (albuterol/budesonide) demonstrated statistically significant and clinically meaningful reduction in the risk of severe exacerbations in patients with intermittent or mild persistent asthma in BATURA Phase III trial
|
Oct 7
|
AstraZeneca and Gilead Sciences merger would be the biggest in the pharma history
|
Aug 30
|
QIAGEN and AstraZeneca Expand Pact to Develop CDx in Chronic Diseases
|
Aug 29
|
Why Is Merck (MRK) Up 3.8% Since Last Earnings Report?
|
Aug 29
|
Qiagen, AstraZeneca expand companion diagnostic pact beyond cancer
|
Aug 29
|
The Zacks Analyst Blog Highlights Visa, AstraZeneca, Disney, FitLife Brands and Utah Medical
|
Aug 29
|
3 UK Stocks Estimated To Be Trading At Up To 46.9% Discount
|
Aug 28
|
Top Analyst Reports for Linde, AstraZeneca & Walt Disney
|
Aug 28
|
AstraZeneca PLC (AZN): A Cheap Pharmaceutical Stock to Buy According to Short Sellers
|
Aug 28
|
Five alternatives to Mag 7 stocks if you missed out on Nvidia
|
Aug 26
|
AstraZeneca (AZN) Denies Rumors About UK Facility Relocation
|